An interventional study of Quiztime modules in Education, sponsored by Vanderbilt University Medical Center. Completed at 1 site in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2020-10-14.
Sponsored by Vanderbilt University Medical Center · Not applicable, Interventional, and Health services research
This study aims to evaluate the impact of spaced education, delivered via a smartphone application, on provider prescribing patterns.
As part of a medical center educational initiative at Vanderbilt University Medical Center (VUMC), two educational modules will be sent to prescribing providers through either email or short message service (SMS) text messaging. The first educational module consists of a set of multiple choice questions concerning best practices for prescribing intravenous fluids in the inpatient and perioperative setting. This module is based upon recent literature and specifically derived from the results of the Isotonic Solutions and Major Adverse Renal Events Trial (SMART) and Saline Against Lactated Ringer's or Plasma-Lyte in the Emergency Department (SALT-ED) trial, both published in the New England Journal of Medicine in 2018 and led by Vanderbilt investigators. Similarly, a second educational module concerning evidence-based pain management and opioid prescribing practices will be distributed via email or SMS text messaging.
Participants will receive one question per day. If the participant does not answer the question correctly, they will receive the opportunity to attempt the question again after reviewing evidence-based education. All questions have been curated and reviewed by a panel of experts and piloted within VUMC for feasibility and acceptability. Key concepts are repeated in each module and questions are strategically ordered throughout each module to accomplish spaced education.
Vanderbilt University Medical Center is the lead sponsor of 824 studies on the registry; 164 are open to participants now.
Of its 122 completed or terminated interventional studies of FDA-regulated products, 91 (75%) have results posted.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
The providers in this arm will first receive daily information and questions related to opioid use for eight weeks and then daily information and questions related to intravenous fluid prescribing for five weeks.
Behavioral: Quiztime modules
The providers in this arm will first receive daily information and questions related to intravenous fluid prescribing for five weeks and then daily information and questions related to opioid use for eight weeks.
Behavioral: Quiztime modules
Text Messaging or Email system
Median morphine milligram equivalents (MME) per opioid prescription
By extracting prescribing data for opioids from the electronic health records
Time frame: 8 months
Percentage of orders for balanced intravenous (IV) fluid solutions (i.e. not normal saline)
By extracting prescribing data for intravenous fluids from the electronic health records
Time frame: 8 months
Chloride levels in patients receiving intravenous fluid orders from a provider enrolled in the study
By extracting chloride level data from the electronic health records
Time frame: 8 months
Potassium levels in patients receiving intravenous fluid orders from a provider enrolled in the study
By extracting potassium level data from the electronic health records
Time frame: 8 months
Major Adverse Kidney Events by 30 days (MAKE 30) in patients receiving intravenous fluid orders from a provider enrolled in the study
By extracting data from the electronic health records
Time frame: 30 days
Length of stay for patients receiving an intravenous fluid order or an opioid prescription from a provider enrolled in the study.
By extracting length of stay data from the electronic health records
Time frame: 8 months
Length of stay in the intensive care unit (ICU) for patients receiving an intravenous fluid order or an opioid prescription from a provider enrolled in the study
By extracting ICU length of stay from the electronic health records
Time frame: 8 months
Median number of pills per prescription for patients receiving an opioid prescription from a provider enrolled in the study
By extracting medication data from the electronic health records
Time frame: 8 months
Percent of opioid prescriptions (inpatient) that also had a scheduled (not pro re nata (PRN)) non-opioid (APAP, nonsteroidal anti-inflammatory drugs (NSAIDs), gamma-Aminobutyric acid (GABA), muscle relaxant, etc.)
By extracting medication data from the electronic health records
Time frame: 8 months
Percent of opioid prescriptions (discharge) that also had a scheduled (not PRN) non-opioid (APAP, NSAIDs, GABA, muscle relaxant, etc.)
By extracting medication data from the electronic health records
Time frame: 8 months
Number of Rapid Response Team calls (RRT s) indexed to the number of patients cared for per prescriber (evaluated by level of engagement of the learner with QuizTime)
By extracting RRT calls from the electronic health records
Time frame: 8 months
Plan to share: Yes — Data dictionaries and individual participant data that underlie the results reported after de-identification will be available.
Supporting information: Study protocol, Sap, Analytic code
This study is completed, as verified in Oct 2020. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Vanderbilt University Medical Center